Kevin D. Cooksy
Plus aucun poste en cours
Profil
Kevin D.
Cooksy worked as a Director of New Business Opportunities at Nektar Therapeutics, a Vice President at ThermoGenesis Holdings, Inc. from 2011 to 2012, a Principal at Agilent Technologies, Inc., and a Vice President of Business Development at Perlegen Sciences, Inc. from 2007 to 2010.
He also served as Secretary & Treasurer at Reflect Scientific, Inc. from 2005 to 2011 and was a Principal at Gerent LLC.
Cooksy holds an MBA from Lake Forest College, an undergraduate degree from Northern Illinois University, and a graduate degree from McGeorge School of Law.
Anciens postes connus de Kevin D. Cooksy
| Sociétés | Poste | Fin |
|---|---|---|
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Corporate Officer/Principal | 01/01/2010 |
| THERMOGENESIS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
| Gerent LLC | Corporate Officer/Principal | - |
Formation de Kevin D. Cooksy
| Lake Forest College | Masters Business Admin |
| Northern Illinois University | Undergraduate Degree |
| Mcgeorge School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| AGILENT TECHNOLOGIES, INC. | Commercial Services |
| REFLECT SCIENTIFIC, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
| Gerent LLC |
